Bedoelde u
safety

Zoekresultaten - 158 results

Risk assessment for contained use of GMOs

equipment and biological waste management) to be adopted. Service:  Biosafety and biotechnology Biosécurité et biotechnologie Bioveiligheid en biotechnologie Category:  C32 ...

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.

in clinical trials. Indeed, these vaccines administered to volunteers raise biosafety concerns with respect to human health and the environment that need to be assessed and managed. Health Topics:  ...

Engineering nucleases for gene targeting: safety and regulatory considerations.

Biosafety and biotechnology Manuscript versions:  DOI:  https://doi.org/10.1016/j.nbt.2013.07.001 File:  Version:  Published Full text access:  Restricted Access Full text language:  English Category:  A1 FOS ...

Surrogate species selection for assessing potential adverse environmental impacts of genetically engineered insect-resistant plants on non-target organisms

by the participants. Service:  Biosafety and biotechnology Biosécurité et biotechnologie Bioveiligheid en biotechnologie Manuscript versions:  DOI:  http://dx.doi.org/10.4161/gmcr.26560 Version:  ...

Pulmonary artery haemorrhage in newborn calves following bluetongue virus serotype 8 experimental infections of pregnant heifers.

isolation facility (biosafety level 3) with a northern European outbreak strain of Bluetongue virus serotype 8 (BTV-8). The study was terminated 2 months after calving with necropsy of the dams and their ...

General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.

introductory paper gathers general considerations on the biosafety of virus-derived vectors that are used in human gene therapy and/or vaccination. The importance to assess the potential risks for human health ...

Biosafety of viral vectors commonly used in gene therapy and vaccination.

Publication Type: Peer reviewed scientific article Authors: Philippe Herman Source: Curr Gene Ther, Volume 13, Issue 6, p.383-4 (2013) Keywords: Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Va ...

Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.

renowned for its safety, several biosafety aspects need to be considered when performing the risk assessment of a recombinant MVA (rMVA). This paper presents the biosafety issues and the main lessons learned ...

Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 14581

1875-5631 Keywords: a Absence adverse effects application AS assessment Belgium biosafety Case Cell clinic Clinical clinical trial Clinical trials Context Disorder Disorders dissemination Dna editorial effect ...

Laboratory-Acquired Infections in Belgium

Biosafety and biotechnology Full text language:  English Category:  C31 FOS Classification:  3.03 Health sciences ...

QR code

QR code for this page URL